[抗体-药物对抗尿癌的结合物-当前问题和未来发展]
1Dept. of Urology, Iwate Medical University School of Medicine.
Gan to kagaku ryoho. Cancer & chemotherapy
|August 27, 2024
概括
恩福图马布维多丁现在用于晚期泌尿腺癌,改变了治疗选择. 现实世界的数据证实了它的有效性和安全性,新的组合显示出希望.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 尿癌研究 尿癌研究
更多相关视频
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.3K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
